Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2011 5
2013 3
2015 2
2017 1
2019 3
2020 1
2021 1
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].
Boyko AN, Alifirova VM, Lukashevich IG, Goncharova ZA, Greshnova IV, Zaslavsky LG, Kotov SV, Malkova NA, Mishin GN, Parshina EV, Poverennova IY, Prakhova LN, Sivertseva SA, Smagina IV, Totolyan NA, Trinitatsky YV, Trushnikova TN, Khabirov FA, Chefranova JY, Shchur SG, Dudin VA, Pokhabov DV, Bolsun DD, Eremeeva AV, Linkova YN, Zinkina-Orikhan AV. Boyko AN, et al. Among authors: smagina iv. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(7. Vyp. 2):43-52. doi: 10.17116/jnevro202312307243. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37560833 Clinical Trial. Russian.
[Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population].
Sivertseva SA, Prilenskaya AM, Popova EV, Turova EL, Volkova LI, Smagina IV, Elchaninova EY, Afanas'eva AI, Goncharova ZA, Markova EA, Yarosh NM, Bakhtiiarova KZ, Sherman MA, Boyko AN. Sivertseva SA, et al. Among authors: smagina iv. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(9):76-82. doi: 10.17116/jnevro202312309176. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37796071 Russian.
[Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational study].
Shvartsman GI, Skoromets AA, Zhivolupov SA, Kurushina OV, Karpov SM, Baranova NS, Nesterova MV, Smagina IV, Prokopenko SV, Antipenko EA, Novikova LB. Shvartsman GI, et al. Among authors: smagina iv. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(8):88-94. doi: 10.17116/jnevro202212208188. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 36036408 Russian.
Genome-wide significant association with seven novel multiple sclerosis risk loci.
Lill CM, Luessi F, Alcina A, Sokolova EA, Ugidos N, de la Hera B, Guillot-Noël L, Malhotra S, Reinthaler E, Schjeide BM, Mescheriakova JY, Mashychev A, Wohlers I, Akkad DA, Aktas O, Alloza I, Antigüedad A, Arroyo R, Astobiza I, Blaschke P, Boyko AN, Buttmann M, Chan A, Dörner T, Epplen JT, Favorova OO, Fedetz M, Fernández O, García-Martínez A, Gerdes LA, Graetz C, Hartung HP, Hoffjan S, Izquierdo G, Korobko DS, Kroner A, Kubisch C, Kümpfel T, Leyva L, Lohse P, Malkova NA, Montalban X, Popova EV, Rieckmann P, Rozhdestvenskii AS, Schmied C, Smagina IV, Tsareva EY, Winkelmann A, Zettl UK, Binder H, Cournu-Rebeix I, Hintzen R, Zimprich A, Comabella M, Fontaine B, Urcelay E, Vandenbroeck K, Filipenko M, Matesanz F, Zipp F, Bertram L. Lill CM, et al. Among authors: smagina iv. J Med Genet. 2015 Dec;52(12):848-55. doi: 10.1136/jmedgenet-2015-103442. Epub 2015 Oct 16. J Med Genet. 2015. PMID: 26475045
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2].
Boyko AN, Alifirova VM, Lukashevich IG, Goncharova ZA, Greshnova IV, Zaslavsky LG, Kotov SV, Malkova NA, Mishin GN, Parshina EV, Poverennova IY, Prakhova LN, Sivertseva SA, Smagina IV, Totolyan NA, Trinitatsky YV, Trushnikova TN, Khabirov FA, Shchur SG, Artemyeva AV, Bolsun DD, Zinkina-Orikhan AV, Linkova YN. Boyko AN, et al. Among authors: smagina iv. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(4):37-47. doi: 10.17116/jnevro202312304137. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37084363 Clinical Trial. Russian.
[Traumatic brain injury before the multiple sclerosis onset: a relationship with the progression of neurological disorders and pathobiochemical markers of the cerebrospinal fluid].
Elchaninova EY, Afanas'eva AI, Smagina IV, Elchaninova SA. Elchaninova EY, et al. Among authors: smagina iv. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(7. Vyp. 2):72-76. doi: 10.17116/jnevro202312307272. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37560837 Clinical Trial. Russian.
Association of SNPs of CD40 gene with multiple sclerosis in Russians.
Sokolova EA, Malkova NA, Korobko DS, Rozhdestvenskii AS, Kakulya AV, Khanokh EV, Delov RA, Platonov FA, Popova TY, Aref' eva EG, Zagorskaya NN, Alifirova VM, Titova MA, Smagina IV, El' chaninova SA, Popovtseva AV, Puzyrev VP, Kulakova OG, Tsareva EY, Favorova OO, Shchur SG, Lashch NY, Popova NF, Popova EV, Gusev EI, Boyko AN, Aulchenko YS, Filipenko ML. Sokolova EA, et al. Among authors: smagina iv. PLoS One. 2013 Apr 22;8(4):e61032. doi: 10.1371/journal.pone.0061032. Print 2013. PLoS One. 2013. PMID: 23613777 Free PMC article.
24 results